LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.39 | 770.25 | 2681 | 5404 | 0.4961 | 0.5585 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.39 | 770.25 | 2614 | 5404 | 0.4837 | 0.5446 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.61 | 770.25 | 2938 | 5813 | 0.5054 | 0.5827 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.61 | 770.25 | 2870 | 5813 | 0.4937 | 0.5700 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.83 | 770.25 | 3127 | 6223 | 0.5025 | 0.5917 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.83 | 770.25 | 3089 | 6223 | 0.4963 | 0.5853 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 50.05 | 770.25 | 3403 | 6629 | 0.5133 | 0.6135 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 50.05 | 770.25 | 3423 | 6629 | 0.5163 | 0.6166 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 52.27 | 770.25 | 3669 | 7058 | 0.5198 | 0.6297 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 52.27 | 770.25 | 3741 | 7058 | 0.5300 | 0.6397 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 54.49 | 770.25 | 3898 | 7555 | 0.5159 | 0.6360 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 54.49 | 770.25 | 3980 | 7555 | 0.5268 | 0.6464 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 56.71 | 770.25 | 4206 | 8001 | 0.5256 | 0.6532 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 56.71 | 770.25 | 4328 | 8001 | 0.5409 | 0.6672 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 58.94 | 770.25 | 4512 | 8444 | 0.5343 | 0.6682 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 58.94 | 770.25 | 4679 | 8444 | 0.5541 | 0.6858 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 61.16 | 770.25 | 4656 | 8892 | 0.5236 | 0.6650 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 61.16 | 770.25 | 5017 | 8892 | 0.5642 | 0.7006 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.39 | 770.25 | 5119 | 9326 | 0.5489 | 0.6929 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.39 | 770.25 | 5367 | 9326 | 0.5755 | 0.7153 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 65.61 | 770.25 | 5357 | 9736 | 0.5502 | 0.6988 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 65.61 | 770.25 | 5562 | 9736 | 0.5713 | 0.7163 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 67.83 | 770.25 | 5645 | 10078 | 0.5601 | 0.7107 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 67.83 | 770.25 | 5928 | 10078 | 0.5882 | 0.7334 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.05 | 770.25 | 5826 | 10413 | 0.5595 | 0.7135 | MN20160304_L02 | C03 |